Adrenomedullin (AM) (22-52), human

Adrenomedullin (AM) (22-52), human, an NH2 terminal truncated adrenomedullin analogue, is an adrenomedullin receptor antagonist, and also antagonizes the calcitonin generelated peptide (CGRP) receptor in the hindlimb vascular bed of the cat.

Product information

CAS Number: 159899-65-7

Molecular Weight: 2638.09

Formula: C121H193N33O31S

Chemical Name: 3-[(1-{[1-({1-[(1-{[1-({1-[(5-amino-1-{[1-({1-[(1-{[1-({5-amino-1-[(5-amino-1-{[1-({1-[(1-{[1-({1-[(1-carbamoyl-3-methylbutyl)carbamoyl]-2-methylpropyl}carbamoyl)ethyl]carbamoyl}ethyl)carbamoyl]-3-methylbutyl}carbamoyl)-2-(4-hydroxyphenyl)ethyl]carbamoyl}pentyl)carbamoyl]pentyl}carbamoyl)-2-methylpropyl]carbamoyl}ethyl)carbamoyl]-3-(methylsulfanyl)propyl}carbamoyl)-3-carbamoylpropyl]carbamoyl}pentyl)carbamoyl]-4-carbamimidamidobutyl}carbamoyl)-2-(4-hydroxyphenyl)ethyl]carbamoyl}-4-carbamimidamidobutyl)carbamoyl]-2-hydroxyethyl}carbamoyl)-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-hydroxyethyl)carbamoyl]-3-[2-(2-amino-3-phenylpropanamido)-3-hydroxybutanamido]propanoic acid

Smiles: CC(O)C(NC(=O)C(N)CC1C=CC=CC=1)C(=O)NC(CC(O)=O)C(=O)NC(CO)C(=O)NC(CC1C=CC(O)=CC=1)C(=O)NC(CO)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC1C=CC(O)=CC=1)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CCC(N)=O)C(=O)NC(CCSC)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC1C=CC(O)=CC=1)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(N)=O

InChiKey: MMCDBQGTKNYEHP-UHFFFAOYSA-N

InChi: InChI=1S/C121H193N33O31S/c1-62(2)53-85(98(127)164)144-118(184)96(65(7)8)153-100(166)67(10)134-99(165)66(9)136-110(176)86(54-63(3)4)145-112(178)88(57-72-34-40-75(159)41-35-72)147-107(173)79(28-18-21-48-123)138-105(171)80(29-19-22-49-124)143-117(183)95(64(5)6)152-101(167)68(11)135-103(169)84(46-52-186-13)142-109(175)83(44-45-93(126)161)141-104(170)78(27-17-20-47-122)137-106(172)81(30-23-50-132-120(128)129)139-111(177)87(56-71-32-38-74(158)39-33-71)146-108(174)82(31-24-51-133-121(130)131)140-115(181)91(60-155)150-113(179)89(58-73-36-42-76(160)43-37-73)148-116(182)92(61-156)151-114(180)90(59-94(162)163)149-119(185)97(69(12)157)154-102(168)77(125)55-70-25-15-14-16-26-70/h14-16,25-26,32-43,62-69,77-92,95-97,155-160H,17-24,27-31,44-61,122-125H2,1-13H3,(H2,126,161)(H2,127,164)(H,134,165)(H,135,169)(H,136,176)(H,137,172)(H,138,171)(H,139,177)(H,140,181)(H,141,170)(H,142,175)(H,143,183)(H,144,184)(H,145,178)(H,146,174)(H,147,173)(H,148,182)(H,149,185)(H,150,179)(H,151,180)(H,152,167)(H,153,166)(H,154,168)(H,162,163)(H4,128,129,132)(H4,130,131,133)

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vitro:

Adrenomedullin (AM) (22-52), human shows no effect on hindlimb perfusion pressure responses to adrenomedullin (ADM) at 120 nmol. However, Adrenomedullin (AM) (22-52), human selectively and reversibly decreases vasodilator responses to human calcitonin generelated peptide (hCGRP) at 30 nmol, with similar effect to that of CGRP antagonist. Adrenomedullin (AM) (22-52), human competitively inhibits the binding of the Adrenomedullin in a dose-dependent manner, inhibits Adrenomedullin -induced cAMP accumulation in rat vascular smooth muscle cells.

Products are for research use only. Not for human use.